The Other Side of the Story

Read insights exploring COVID-19 treatment developments, including treatment landscape and how they are being used in real-world clinical practice.

aRight now, vaccines are still claiming the majority of public attention – but safe and effective treatments are a critical weapon in our battle against COVID-19, offering hope of turning a potentially fatal virus into an inherently manageable one.

Although only a few treatments have been approved for use so far, the COVID-19 therapy development space is a hive of activity, with numerous manufacturers working on repurposing existing drugs and innovating new treatments.

In this paper, we explore the focus for COVID-19 treatment development, the current COVID-19 treatment landscape and, drawing on real-world data from Ipsos’ new COVID-19 Therapy Monitor, how treatments are being used in real-world clinical practice.

Want more healthcare sector insights? Join us for our webinar on July 21.

Download

The author(s)

  • Rhoda Schmuecking
    President, Global Therapy Monitors

Related news

  • State of the Nation: Heading into the Holiday Season
    Consumers Webinar

    State of the Nation: Heading into the Holiday Season

    We'll examine consumer sentiment and future outlook, unpack evolving U.S.-Canada tensions amid economic policy announcements and tariff threats, and look at how shopping behaviours are changing as consumers balance value, confidence, and spending priorities.
  • [WEBINAR] TOAST 2026: Under Pressure - Fewer Fragmented Fought-For
    Consumers Events replay

    [WEBINAR] TOAST 2026: Under Pressure - Fewer, Fragmented, Fought-For

    Join us for a fresh perspective on where future growth may come from and where traditional approaches are increasingly under pressure.
  • NASPL Possible NW
    Consumer Behavior Event

    NASPL Possible NW

    Join Ipsos as we unveil how lotteries are using mystery shopping to unlock revenue hiding in plain sight, with high-performing retailers generating significantly more revenue per square foot through specific, measurable behaviours that any retailer can replicate.